Home  >  Products  >  PFKP (phosphofructokinase, platelet ) Blocking Peptide (the C terminal of PFKP)(100ug)
PFKP (phosphofructokinase, platelet ) Blocking Peptide (the C terminal of PFKP)(100ug)

PFKP (phosphofructokinase, platelet ) Blocking Peptide (the C terminal of PFKP)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PFKP Antibody (ARP61860_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61860
Size: 100ug
Weight: 85kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The PFKP gene encodes the platelet isoform of phosphofructokinase (PFK) (ATP:D-fructose-6-phosphate-1-phosphotransferase, EC 2.7.1.11). PFK catalyzes the irreversible conversion of fructose-6-phosphate to fructose-1,6-bisphosphate and is a key regulatory enzyme in glycolysis. The PFKP gene, which maps to chromosome 10p, is also expressed in fibroblasts. See also the muscle (PFKM; MIM 610681) and liver (PFKL; MIM 171860) isoforms of phosphofructokinase, which map to chromosomes 12q13 and 21q22, respectively. Vora (1981) [PubMed 6451249] determined that full tetrameric phophofructokinase enzyme expressed in platelets can be composed of subunits P4, P3L, and P2L2.
Alternative names: FLJ40226; PFK-C; PFKF
See Full Product Listings >